Prelude Therapeutics (PRLD) Share-based Compensation (IS) (2019 - 2025)
Prelude Therapeutics (PRLD) reported Share-based Compensation (IS) of $3.81 million for Q2 2025, down 37.5% from $6.1 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
Prelude Therapeutics (PRLD) Share-based Compensation (IS) (2019 - 2025) Analysis & Trends
Over the twelve months ended Jun 30, 2025, Prelude Therapeutics' Share-based Compensation (IS) came in at $19.29 million, down 20.5% year-over-year; for FY2023, it came in at $25.62 million, up 1.9% from FY2022.
- Share-based Compensation (IS) has increased for four consecutive years, with a four-year compound annual growth rate of 134.6% (FY2019 to FY2023).
- By year, Share-based Compensation (IS) came in at $25.14 million in FY2022 (+20.1%), $20.93 million in FY2021 (+274.9%), $5.58 million in FY2020 (+559.9%) and $846,000 in FY2019.
- The Q2 2025 figure ranks as the lowest quarterly Share-based Compensation (IS) since Q4 2020.
- Year over year, Share-based Compensation (IS) gained in two of the last six quarters, with an average decline of 14.0%.
- The high point for year-over-year Share-based Compensation (IS) in five years was Q1 2021 (growth of 973.5%); the low point was Q2 2025 (a decline of 37.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | - |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | - |
| 10 | Prelude Therapeutics | 360.10 Mn | -237.20 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 5.55 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Jun 30, 2023 | 6.73 Mn |
| Mar 31, 2023 | 6.26 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 6.44 Mn |
| Jun 30, 2022 | 6.03 Mn |
| Mar 31, 2022 | 6.83 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 4.24 Mn |
| Mar 31, 2021 | 3.89 Mn |
| Dec 31, 2020 | 3.12 Mn |
| Sep 30, 2020 | 1.47 Mn |
| Jun 30, 2020 | 627,000.00 |
| Mar 31, 2020 | 362,000.00 |
API Access
Prelude Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PRLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "PRLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=PRLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();